NovaBay Pharmaceuticals Inc (NBY)
0.7801
+0.08
(+10.64%)
USD |
NYAM |
Nov 12, 16:00
0.7999
+0.02
(+2.54%)
After-Hours: 20:00
NovaBay Pharmaceuticals Research and Development Expense (Quarterly): 0.009M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.009M |
March 31, 2024 | 0.019M |
December 31, 2023 | 0.004M |
September 30, 2023 | 0.011M |
June 30, 2023 | 0.022M |
March 31, 2023 | 0.01M |
December 31, 2022 | 0.066M |
September 30, 2022 | 0.041M |
June 30, 2022 | 0.04M |
March 31, 2022 | 0.028M |
December 31, 2021 | 0.008M |
September 30, 2021 | 0.01M |
June 30, 2021 | 0.021M |
March 31, 2021 | 0.005M |
December 31, 2020 | 0.036M |
September 30, 2020 | 0.125M |
June 30, 2020 | 0.115M |
March 31, 2020 | 0.009M |
December 31, 2019 | 0.018M |
September 30, 2019 | 0.049M |
June 30, 2019 | 0.032M |
March 31, 2019 | 0.085M |
December 31, 2018 | 0.107M |
September 30, 2018 | 0.045M |
June 30, 2018 | 0.061M |
Date | Value |
---|---|
March 31, 2018 | 0.046M |
December 31, 2017 | 0.146M |
September 30, 2017 | 0.132M |
June 30, 2017 | 0.07M |
March 31, 2017 | 0.062M |
December 31, 2016 | 0.156M |
September 30, 2016 | 0.004M |
June 30, 2016 | 0.278M |
March 31, 2016 | 0.933M |
December 31, 2015 | 1.225M |
September 30, 2015 | 1.563M |
June 30, 2015 | 1.357M |
March 31, 2015 | 1.583M |
December 31, 2014 | 2.405M |
September 30, 2014 | 2.312M |
June 30, 2014 | 2.238M |
March 31, 2014 | 2.528M |
December 31, 2013 | 4.037M |
September 30, 2013 | 2.513M |
June 30, 2013 | 2.937M |
March 31, 2013 | 2.925M |
December 31, 2012 | 2.119M |
September 30, 2012 | 2.514M |
June 30, 2012 | 2.378M |
March 31, 2012 | 2.264M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.004M
Minimum
Dec 2023
0.125M
Maximum
Sep 2020
0.0314M
Average
0.019M
Median
Mar 2024
Research and Development Expense (Quarterly) Benchmarks
Palatin Technologies Inc | 4.672M |
iBio Inc | 1.14M |
Theriva Biologics Inc | 2.953M |
Oragenics Inc | 0.9068M |
Nanoviricides Inc | 1.182M |